Evaluating functional recovery in idiopathic normal pressure hydrocephalus presents distinct clinical challenges. Clinicians frequently encounter diagnostic ambiguity because conventional gait assessments remain variably standardized and episodic. However, integrating wearable step counts in iNPH offers continuous, real-world mobility tracking before and after ventriculoperitoneal shunt surgery. This digital approach bridges the gap between brief clinical exams and everyday functional capacity, providing surgeons and neurologists with granular physiological data.

The Clinical Challenge of Assessing Mobility in iNPH

Idiopathic normal pressure hydrocephalus classically presents with the triad of gait disturbance, cognitive impairment, and urinary incontinence. Among these symptoms, gait impairment usually appears first and responds best to cerebrospinal fluid diversion. However, traditional evaluations rely on in-clinic walking tests, such as timed up-and-go protocols or brief gait velocity assessments. Consequently, these snapshot examinations often capture performance at a single moment rather than true functional capacity. White-coat effects, transient fatigue, and patient anxiety can skew results significantly. Furthermore, patient-reported outcomes carry inherent recall bias, especially when mild cognitive impairment coexists. Therefore, neurosurgeons and neurologists need reliable, continuous, and non-invasive tools to quantify mobility during routine daily life. Wearable digital health technologies have emerged as a practical solution. By collecting objective longitudinal data, continuous monitoring provides an unbiased window into real-world patient mobility.

Study Design and Evaluating Wearable Step Counts in iNPH

A recent prospective pilot investigation evaluated perioperative mobility patterns in patients undergoing ventriculoperitoneal shunt implantation for idiopathic normal pressure hydrocephalus. Researchers equipped participants with wrist-worn activity monitors to continuously capture real-life daily activity. The study protocol recorded baseline activity before surgery and tracked ongoing movement throughout the postoperative period. Specifically, the primary endpoint assessed changes in mean daily step counts following shunt placement. Secondary analyses compared objective responders against non-responders, characterized the longitudinal time course of recovery, and examined correlations with subjective clinical improvement. Additionally, investigators conducted exploratory receiver operating characteristic curve analysis to establish predictive thresholds. By tracking continuous activity, the investigators avoided the artificial constraints of clinical environments. Consequently, this methodology highlights how real-world digital tracking can quantify postoperative functional changes accurately in vulnerable geriatric cohorts.

Key Findings and Time Course of Postoperative Functional Gains

The prospective trial demonstrated clear distinctions between patient subgroups following ventriculoperitoneal shunt surgery. Although overall cohort metrics showed modest numerical increases, distinct stratification emerged between objective responders and non-responders. Objective responders, comprising two-thirds of the cohort, exhibited a significant increase in daily physical activity. Their mean daily step counts improved substantially from baseline levels, reflecting meaningful real-life functional restoration. Interestingly, longitudinal tracking revealed that mobility gains did not occur overnight. Instead, measurable improvements began emerging around postoperative week nine and reached peak levels near week eleven. This timeline underscores that neurological recovery and gait adaptation after cerebrospinal fluid diversion require sustained periods. Furthermore, objective improvements strongly correlated with subjective clinical reports. Specifically, 87.5 percent of objective responders confirmed noticeable symptomatic relief, establishing a strong linear association between wearable data and patient satisfaction.

Predictive Value and Clinical Utility of Step Count Thresholds

Beyond tracking recovery kinetics, the study explored whether baseline activity levels could predict surgical success. Exploratory receiver operating characteristic analysis identified a baseline threshold of 1881 steps per day as a discriminatory marker. Patients who exceeded this preoperative threshold demonstrated a higher likelihood of achieving meaningful postoperative mobility improvements. The calculated area under the curve reached 0.875, reflecting high sensitivity and specificity within this pilot cohort. Although clinicians must interpret these exploratory values cautiously, the findings emphasize an essential physiological concept. Specifically, patients who maintain a modest reserve of baseline physical activity may possess superior neuroplastic capacity following shunt placement. Therefore, capturing preoperative baseline metrics could help clinicians stratify candidates, refine surgical indications, and manage family expectations during preoperative counseling.

Integrating Wearables into Neurosurgical Follow-Up

Integrating wearable trackers into routine neurosurgical practice offers multifaceted benefits for ongoing care. Continuous step tracking allows clinical teams to monitor shunt functionality remotely and detect secondary decline early. If a patient experiences sudden reductions in daily steps, clinicians can investigate potential shunt obstruction, overdrainage, or subdural fluid collections promptly. Additionally, objective mobility tracking serves as a powerful motivator for patients during neurorehabilitation. Seeing measurable increases in daily steps encourages adherence to physical therapy and lifestyle modifications. Moreover, digital tracking supports interdisciplinary communication between neurosurgeons, neurologists, physiotherapists, and primary care physicians. By replacing subjective impressions with hard digital endpoints, multidisciplinary teams can tailor postoperative rehabilitation protocols to individual patient recovery trajectories effectively.

Future Directions and Broader Clinical Implications

While these initial pilot findings show substantial promise, widespread clinical adoption requires further multicenter validation. Future studies must incorporate larger, diverse patient populations to confirm predictive cut-offs and establish standardized monitoring protocols. Additionally, incorporating advanced kinematic metrics, such as stride regularity, turning velocity, and gait symmetry, could provide deeper qualitative insights into neurological recovery. Coupling wearable sensors with automated machine learning algorithms may also predict shunt complications before overt clinical deterioration occurs. Ultimately, continuous digital mobility tracking represents a transformative paradigm shift in neurosurgery. By capturing objective, real-life patient metrics, digital biomarkers will refine candidate selection, optimize surgical timing, and elevate the standard of care for hydrocephalus management worldwide.

Frequently Asked Questions (FAQs)

How do wearable trackers improve assessment compared to standard clinic gait tests?

Standard clinic tests capture only brief, isolated snapshots of patient performance, which anxiety or fatigue can distort. In contrast, wearable trackers continuously record authentic daily movement over weeks, delivering unbiased, objective data regarding real-world functional capacity and daily physical activity.

When do patients typically show peak mobility gains after shunt surgery?

Continuous monitoring demonstrates that functional recovery evolves gradually rather than immediately after surgery. Significant mobility improvements typically emerge around postoperative week nine, with peak step counts occurring near postoperative week eleven as the brain adapts to restored cerebrospinal fluid dynamics.

Can preoperative step counts predict which patients will benefit from shunt placement?

Preliminary research suggests that a baseline threshold around 1881 steps per day discriminates potential responders from non-responders. Patients maintaining this activity reserve often demonstrate better post-surgical mobility gains, though larger prospective trials must validate this predictive metric.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Healthcare professionals should exercise independent clinical judgment and verify all medical decisions against institutional protocols. Refer to the latest local and national guidelines for clinical practice.

References

1. Meška D et al. Perioperative real-life mobility assessment using wearable step counts in idiopathic normal pressure hydrocephalus after ventriculoperitoneal shunt surgery: a prospective pilot study. Neurosurg Rev. 2026 Aug 13. doi: 10.1007/s10143-026-04432-5. PMID: 42587163.
2. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3 Suppl):S4-S16.
3. Halperin JJ, Kurlan R, Schwalb JM, et al. Practice guideline: Idiopathic normal pressure hydrocephalus: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2015;85(23):2063-2071.